What are the therapeutic effects and common side effects of sertraline (Zoloft)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Sertraline: Therapeutic Effects and Side Effects

Sertraline is an effective SSRI antidepressant with comparable efficacy to other second-generation antidepressants for treating depression and anxiety disorders, but carries a distinctly higher risk of diarrhea compared to other SSRIs, along with common side effects including nausea, sexual dysfunction, and increased risk of suicidal behavior in some patients.

Therapeutic Effects

Sertraline demonstrates equivalent efficacy to other SSRIs for treating major depressive disorder, with no clinically significant differences in effectiveness, quality of life outcomes, or remission rates 1. The medication works across diverse patient populations—showing equal effectiveness regardless of age (including elderly patients over 65), sex, race, or comorbid medical conditions 1.

For anxiety disorders in children and adolescents (ages 6-18), sertraline combined with CBT shows superior outcomes compared to either treatment alone, with moderate strength of evidence for improving primary anxiety symptoms, global function, and achieving disorder remission 2.

The drug has a linear pharmacokinetic profile with a half-life of approximately 26 hours, making once-daily dosing appropriate 3, 4. Therapeutic response increases with dosage, though the optimal balance between efficacy and tolerability appears to be in the 50-150 mg daily range 5.

Important efficacy considerations:

  • 38% of patients do not achieve treatment response during 6-12 weeks of treatment 1
  • 54% do not achieve full remission 1
  • Mirtazapine shows faster onset of action than sertraline 1

Common Side Effects

Gastrointestinal Effects (Most Distinctive)

Sertraline has a significantly higher rate of diarrhea than all other second-generation antidepressants including bupropion, citalopram, fluoxetine, fluvoxamine, mirtazapine, nefazodone, paroxetine, and venlafaxine 1. The FDA label confirms diarrhea as one of the most common adverse reactions 6.

Other frequent GI effects include:

  • Nausea (most common reason for discontinuation in clinical trials) 1, 6
  • Loss of appetite 6
  • Indigestion/dyspepsia 6

Sexual Dysfunction

Sexual side effects occur frequently but are less severe than with paroxetine 1. In males, sertraline causes:

  • Ejaculation failure (8% vs 1% placebo) 6
  • Decreased libido (6% vs 2% placebo) 6
  • Erectile dysfunction (4% vs 1% placebo) 6

In females: decreased libido is the primary concern 6. Sexual dysfunction rates are likely underreported as patients and providers may be reluctant to discuss these issues 6.

Neuropsychiatric Effects

  • Insomnia (20% vs 13% placebo) 6
  • Tremor (9% vs 2% placebo) 6
  • Dizziness (12% vs 8% placebo) 6
  • Somnolence (11% vs 6% placebo) 6
  • Agitation (8% vs 5% placebo) 6
  • Headache 1

Other Common Effects

  • Increased sweating/hyperhidrosis (7% vs 3% placebo) 1, 6
  • Fatigue (12% vs 8% placebo) 6
  • Constipation 1

Weight Effects

Sertraline causes less weight gain than mirtazapine or paroxetine 1, making it a favorable choice when weight concerns are present.

Serious Adverse Effects

Suicidality Risk

SSRIs including sertraline increase the risk of nonfatal suicide attempts (OR 1.57-2.25 compared to placebo), though completed suicide risk is not increased 1. This risk requires:

  • Close monitoring, especially in the first 24-48 hours after dose changes 2
  • Particular vigilance in children and adolescents 2
  • Parental oversight of medication regimens in young patients 2

Discontinuation Syndrome

Sertraline is associated with discontinuation syndrome (though less severe than paroxetine) 2. Symptoms include dizziness, fatigue, myalgias, nausea, sensory disturbances, and anxiety when doses are missed or the drug is abruptly stopped 2.

Rare but Serious Events

  • Serotonin syndrome (contraindicated with MAOIs; use caution with other serotonergic drugs) 2, 6
  • QTc prolongation (post-marketing reports; use caution in patients with risk factors) 6
  • Hyponatremia 1
  • Increased bleeding risk 6
  • Seizures (rare) 1
  • Activation of mania/hypomania 6

Key Prescribing Considerations

Advantages Over Tricyclics

  • Minimal anticholinergic effects 1, 4
  • No significant cardiovascular toxicity 1, 4, 7
  • Wide safety margin in overdose 3, 7
  • Suitable for elderly patients and those with cardiovascular disease 4, 8

Drug Interactions

Sertraline has a relatively low potential for cytochrome P450 interactions compared to other SSRIs 2, 8. It mildly inhibits CYP2D6 but has minimal effects on other isoenzymes 3. However, it is highly protein-bound and may affect levels of other protein-bound medications 3.

Special Populations

  • No dosage adjustment needed for elderly patients based on age alone 8
  • Pregnancy: discuss risks/benefits (potential neonatal withdrawal and lung problems) 6
  • Breastfeeding: small amounts pass into breast milk 6

Clinical Pitfalls to Avoid

  1. Don't ignore the diarrhea risk: Sertraline's distinctly higher diarrhea rate may impact adherence and quality of life
  2. Screen for sexual dysfunction proactively: Patients rarely volunteer this information 6
  3. Monitor for activation: Initial anxiety/agitation may occur; consider starting with subtherapeutic "test" doses 2
  4. Avoid abrupt discontinuation: Taper to prevent withdrawal syndrome 2
  5. Watch for dose-dependent side effects: Adverse reactions increase above 150 mg daily 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.